Siberian State Medical University (SSMU) is working on creating an "organ-on-a-chip" technology. It will allow assessing the toxicity of gene-therapeutic drugs. This was reported by the university's press service.
"Organ-on-a-chips" are microfluidic platforms that are revolutionizing the pharmaceutical and medical industries. The project aims to create a model of a secondary human liver tumor node, compatible with a microfluidic chip, for screening promising gene therapy products belonging to the class of advanced medicinal products, and RNA-based drugs.
Scientists will create and combine with microfluidic technologies a liver organoid with implanted single tumor cells — micrometastases. The project implementation will contribute to the development of cell biology, pharmacy and pharmacology.
Earlier www1.ru reported that in Nizhny Novgorod they are growing an artificial organ in a test tube.
Read related materials:
Blood vessels, stomach, intestines: astronauts on the ISS will begin printing human organs
A technology for 3D printing human tissue from living cells has been developed in Russia
